$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
用达希纳治疗白血病能活多久?
2025-10-19 11:44:20
Check Details
哪些白血病不适合使用达希纳?
2025-10-19 11:44:20
Check Details
使用达希纳治疗慢性髓性白血病的费用贵吗?
2025-10-19 11:44:20
Check Details
伊马替尼耐药后的选择-达希纳
2025-10-19 11:44:20
Check Details
白血病患者使用达希纳治疗时的禁忌和注意事项
2025-10-19 11:44:20
Check Details
雷德帕斯是FLT3突变阳性急性髓细胞白血病(AML)的突破治疗方案
2025-10-19 11:44:20
Check Details
白血病FJT3抑制剂富马酸吉列替尼图片及介绍
2025-10-19 11:44:20
Check Details
达希纳可以作为慢性髓性白血病的一线用药吗?
2025-10-19 11:44:20
Check Details
富马酸吉列替尼的出现,给白血病患者带来了新的选择
2025-10-19 11:44:20
Check Details
Idhifa可治疗复发或难治性急性髓性白血病成年患者
2025-10-19 11:44:20
Check Details
雷德帕斯可显著改善急性髓系白血病的无进展生存期
2025-10-19 11:44:20
Check Details
FDA批准Idhifa用于急性髓性白血病的治疗
2025-10-19 11:44:20
Check Details
1
2
...
4913
4914
4915
4916
4917
4918
4919
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
2
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
3
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
4
Pralsetinib and Hypertension in NSCLC: Risks, Monitoring and Management
5
Tucatinib Overview: HER2-Positive Breast Cancer and RAS Wild-Type Colorectal Cancer Dosing, Brain Metastases Data and Safety
6
FDA Approves Durvalumab Plus Enfortumab Vedotin for Perioperative Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
7
Bepirovirsen (Hibsago) Prescribing Information: Indications, Boxed Warnings, Dose Adjustment and Monitoring
8
Avapritinib (Ayvakit) Prescribing Information: Indications, Dosage, Adverse Reactions and Safety Warnings
9
Daraxonrasib Pregnancy, Lactation and Contraception Safety
10
Afatinib Side Effects and Safety Management
11
Capmatinib for MET Exon 14 Non-Small Cell Lung Cancer
12
Ibrutinib for CLL/SLL: Not for Immediate Use at Diagnosis